Join to View Full Profile
1515 Holcombe BlvvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Ludwig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Asst. Professor at MD Anderson Cancer Center, Dept. of Sarcoma Medical Oncology. Primary research focus on Ewing sarcoma and DSRCT.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1998 - 2001
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2000 - Present
TX State Medical License 2006 - 2026
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma Start of enrollment: 2025 Feb 25
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare Disease.Riddhi R Patel, Andrew J Bishop, Alexander J Lazar, Patrick P Lin, Robert S Benjamin
Cancers. 2025-02-22 - Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?Riddhi R Patel, George L Delclos, Stacia M DeSantis, Michael B Cannell, Philip J Lupo
American Journal of Clinical Oncology. 2025-01-01 - Anti-CD137 agonist antibody-independent and clinically feasible preparation of tumor-infiltrating lymphocytes from soft tissue sarcoma and osteosarcoma.Yining Jin, Zhiliang Jia, Xueqing Xia, Nancy B Gordon, Joseph A Ludwig
Frontiers in Immunology. 2025-01-01
Journal Articles
- Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient SurvivalAlexander J Lazar, Joseph A Ludwig, Cynthia E Herzog, Raphael E Pollock, Clinical Cancer Research
- Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing SarcomaJoseph Ludwig IV, MD, Clinical Cancer Research
Press Mentions
- Oncternal Therapeutics Announces Presentation of Interim Phase 1 Clinical Trial Data for TK216 in Patients with Relapsed/Refractory Ewing Sarcoma at CTOS 2020 Virtual Annual MeetingNovember 11th, 2020
Oncternal Therapeutics Announces Presentation of Interim Phase 1 Clinical Trial Data for TK216 in Patients with Relapsed/Refractory Ewing Sarcoma at ESMO Virtual Congress 2020September 21st, 2020- MD Anderson Researchers Receive Over $25.5 Million in CPRIT FundingFebruary 23rd, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
